On September 11, 2023, the FDA approved updated COVID-19 vaccines from Pfizer and Moderna 

The authorization extended to individuals aged 6 months and older, as recommended by the ACIP on September 12 

The CDC Director adopted the ACIP's recommendation on the same day 

This approval marked the first instance of COVID-19 vaccines transitioning to the commercial market 

Previously, the federal government had provided vaccines free of charge to all, regardless of insurance or financial status 

Pfizer and Moderna are charging $115 and $128 per dose, respectively, in the commercial market 

These prices are approximately 3-4 times higher than what the federal government paid 

Additional costs may apply for vaccine administration and provider visits 

Insurance market rules will now dictate how COVID-19 vaccines are paid for and covered 

Due to the Affordable Care Act and pandemic-related laws, vaccines will remain free for most individuals with insurance, but uninsured adults may not have guaranteed free access